Association between gene expression of metabolizing enzymes and esophageal squamous cell carcinomas in china

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 10, 2012, Pages 1211-1217

  Liu, Ran ^a   Yin, Lihong ^a   Pu, Yuepu ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE P1; MESSENGER RNA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); QUINONE 1; QUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; CASE REPORT; CHINA; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; CYTOCHROME P-450 CYP2E1; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; GLUTATHIONE S-TRANSFERASE PI; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); REGRESSION ANALYSIS; RISK ASSESSMENT;

EID: 84867531510     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0032     Document Type: Article

References (38)

1. Borovecki F, Lovrecic L, Zhou J, et al. (2005) Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci U S A 102:11023-11028.
2. Brabender J, Lord RV, Wickramasinghe K, et al. (2002) Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocar-cinoma. J Gastrointest Surg 6:359-367.
3. Cai L, Zheng ZL, Zhang ZF (2005) Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer. World J Gastroenterol 11:1867-1871.
4. Choi SW, Mason JB (2000) Folate and carcinogenesis: an integrated scheme. J Nutr 130:129-132.
5. Cobbe SC, Scobie GC, Pohler E, et al. (2003) Alteration of glu-tathione S-transferase levels in Barrett's metaplasia compared to normal oesophageal epithelium. Eur J Gastroenterol He-patol 15:41-47.
6. Duzkale H, Schweighofer CD, Coombes KR, et al. (2011) LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients. Blood 117:4076-4084.
7. Friso S, Choi SW (2005) Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 6:37-46.
8. Furukawa M, Nishimura M, Ogino D, et al. (2004) Cytochrome p450 gene expression levels in peripheral blood mononu-clear cells in comparison with the liver. Cancer Sci 95:520-529.
9. Gatta L, Cardinale A, Wannenes F, et al. (2009) Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs. Neurosci Lett 453:36-40.
10. Godoy W, Albano RM, Moraes EG, et al. (2002) CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism. Carcinogenesis 23:611-616.
11. Gui YX, Wan Y, Xiao Q, et al. (2011) Verification of expressions of Kir2 as potential peripheral biomarkers in lymphocytes from patients with Parkinson's disease. Neurosci Lett 505:104-108.
12. Horiike N, Abe M, Kumagi T, et al. (2005) The quantification of cytochrome P-450 (CYP 3A4) mRNA in the blood of patients with viral liver diseases. Clin Biochem 38:531-534.
13. Kamangar F, Strickland PT, Pourshams A, et al. (2005) High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res 25:425-428.
14. Krovat BC, Tracy JH, Omiecinski CJ (2000) Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells. Toxicol Sci 55:352-360.
15. Kuwano H, Kato H, Miyazaki T, et al. (2005) Genetic alterations in esophageal cancer. Surg Today 35:7-18.
16. Lechevrel M, Casson AG, Wolf CR, et al. (1999) Characterization of cytochrome P450 expression in human oesophageal mu-cosa. Carcinogenesis 20:243-248.
17. Lin K, Shen ZY, Lu SH, et al. (2002) Intake of volatile N-nitrosamines and their ability to exogenously synthesize in the diet of inhabitants from high-risk area of esopha-geal cancer in southern China. Biomed Environ Sci 15:277-282.
18. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
19. Long DJ, 2nd, Waikel RL, Wang XJ, et al. (2001) NAD(P)H:qui-none oxidoreductase 1 deficiency and increased susceptibility to 7, 12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. J Natl Cancer Inst 93:1166-1170.
20. Lu D, Yu X, Du Y (2011) Meta-analyses of the effect of cyto-chrome P450 2E1 gene polymorphism on the risk of head and neck cancer. Mol Biol Rep 38:2409-2416.
21. Malik MA, Upadhyay R, Mittal RD, et al. (2010) Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer 62:734-742.
22. Novak RF, Woodcroft KJ (2000) The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression. Arch Pharm Res 23:267-282.
23. Oyama T, Matsumoto A, Isse T, et al. (2003) Evidence-based prevention (EBP): approach to lung cancer prevention based on cytochrome 1A1 and cytochrome 2E1 polymorphism. Anticancer Res 23:1731-1737.
24. Rasmi Y, Allameh A, Nasseri-Moghaddam S, et al. (2006) Comparison of glutathione S-transferase-Pi expression at mRNA levels in oesophageal mucosa using RT-PCR-ELISA in individuals with reflux diseases, adenocarcinoma and squa-mous cell carcinoma. Clin Biochem 39:997-1001.
25. Reddy AJ, Christie JD, Aplenc R, et al. (2009) Association of human NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphism with development of acute lung injury. J Cell Mol Med 13:1784-1791.
26. Runne H, Kuhn A, Wild EJ, et al. (2007) Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. Proc Natl Acad Sci U S A 104:14424-14429.
27. Sameer AS, Shah ZA, Syeed N, et al. (2010) NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and co-lorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac J Cancer Prev 11:209-213.
28. Stankova J, Lawrance AK, Rozen R (2008) Methylenetetrahy-drofolate reductase (MTHFR): a novel target for cancer therapy. Curr Pharm Des 14:1143-1150.
29. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, et al. (2003) Esophageal and gastric cardia cancer risk and folate-and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 12:1222-1226.
30. Strange RC, Spiteri MA, Ramachandran S, et al. (2001) Glutathione-S-transferase family of enzymes. Mutat Res 482:21-26.
31. Sumner CJ, Kolb SJ, Harmison GG, et al. (2006) SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials. Neurology 66:1067-1073.
32. Tanaka E, Terada M, Misawa S (2000) Cytochrome P450 2E1: its clinical and toxicological role. J Clin Pharm Ther 25:165-175.
33. Tang Y, Lu A, Aronow BJ, et al. (2001) Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol 50:699-707.
34. Terrier P, Townsend AJ, Coindre JM, et al. (1990) An immu-nohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol 137:845-853.
35. Vasiliou V, Ross D, Nebert DW (2006) Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Hum Genomics 2:329-335.
36. Wang LD, Guo RF, Fan ZM, et al. (2005) Association of methy-lenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus 18:177-184.
37. Wang XW, Xu M, Wang WQ, et al. (2009) Down-regulated expression of cytochrome P450 (CYP) involved in the development and progression of esophageal adenocarcinoma. Hepatogastroenterology 56:1371-1376.
38. Wang YH, Lee YH, Tseng PT, et al. (2008) Human NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfo-transferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan. J Cancer Res Clin Oncol 134:203-209.